Fred Hutch public health researchers Drs. Scott Ramsey and Veena Shankaran welcomed stakeholders to the 2024 Value in Cancer ...

As part of an international collaboration, Fred Hutch scientists provided structural information that helped reveal how two ...

Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to ...

On Aug. 10, 2024, more people than ever before experienced cheers, sun and community as they joined up in Seattle and ...

Dr. Nicole Fleming, a gynecologic oncologist specializing in the treatment of gynecologic malignancies with both surgical and ...

Fred Hutch Cancer Center brought together a host of experts on November 2 to share tips, tools, resources and strategies for ...

Fred Hutch Cancer Center researchers developing immunotherapies using engineered adaptive immune system cells have received ...

As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...

Dr. Ross Prentice, former senior vice president and director of the Hutch’s Public Health Sciences Division, is a biostatistician who develops methods used in the design and analysis of clinical and ...

Associate Professor, Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch Associate Professor, Herbold Computational Biology Program Public Health Sciences Division, Fred ...

Dr. Andrew Cowan is a hematologist-oncologist who specializes in treating patients with multiple myeloma and other blood disorders. He leads clinical trials of new treatments for these diseases, ...

The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, ...